Screening e comunicazione

1. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO, 1968. http://www.who.int/bulletin/volumes/86/4/07-050112BP.pdf. 2. Turnbull C, Firth HV, Wilkie AOM, et al. Population screening requires robust evidence-genomics is no exception. Lancet 2024;403 (10426):583-6. doi: 10.1016/S0140-6736(23) 02295-X. 3. Andermann A, Blancquaert I, Beauchamp S, Déry V. Revisiting Wilson and Jungner in the genomic age: a review of screening criteria over the past 40 years. Bull World Health Organ 2008;86(4):317-9. doi: 10.2471/ blt.07.050112. 4. Tornese G, Greco L. Screening per diabete mellito tipo 1 e celiachia: intenzioni, pregi e difetti. Medico e Bambino 2024;43(4):249-53. doi: 10.53126/MEB43249. 5. Cocchi S, Cipolat Mis C, Mazzocut M and Ethic Validation Group. Content and Face Validity of the Evaluation Tool of Health Information for Consumers (ETHIC): Getting Health Information Accessible to Patients and Citizens. Healthcare (Basel) 2023;11(8):1154. doi: 10.3390/healthcare11081154. 6. https://www.gov.uk/government/organisations/uk-national-screening-committee.